Company / Accounts Receivable
Pulmatrix, Inc. Accounts Receivable History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$928.0K
FY2023
5-year range
$67.0K / $1.3M
FY2019-FY2023
Trend
-28.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $67,000 to $928,000 over the past 2 years.
Based on SEC 10-K filings.
$928,000 in FY2023 with a 3-year CAGR of +122.7%.
Improved from $67,000 to $928,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +122.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +122.7%, indicating consistent growth.
- In FY2023, accounts receivable decreased 28.5% year-over-year.
- Peak accounts receivable was recorded in FY2019.
- Lowest accounts receivable in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.56 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $928.0K | -28.5% |
| FY2022 | $1.3M | +1837.3% |
| FY2021 | $67.0K | -20.2% |
| FY2020 | $84.0K | -98.8% |
| FY2019 | $7.2M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026